Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06394414
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2024-04-23
Brief Title:
A Phase 1 Study to Evaluate the Safety Efficacy and Pharmacokinetics of YL201 in Advanced Solid Tumors
Sponsor:
MediLink Therapeutics Suzhou Co Ltd
Organization:
MediLink Therapeutics Suzhou Co Ltd
Organization Data
Organization:
MediLink Therapeutics Suzhou Co Ltd
Class:
INDUSTRY
Study ID:
YL201-CN-102-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MediLink Therapeutics Suzhou Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None